Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	May 05, 2013		Apr. 29, 2012
OPERATING ACTIVITIES
Net (loss) income	$ (20,013)		$ 95,476
Adjustments to reconcile to net cash used by operating activities:
Depreciation and amortization	95,843		33,459
Equity in income of unconsolidated affiliates, net	(2,327)		(1,924)
Deferred taxes	(37,129)		5,330
Stock-based compensation expense	18,897		10,516
Debt modification and extinguishment costs	40,395		0
Changes in operating assets and liabilities:
Trade receivables, net	(69,356)		(61,611)
Inventories, net	170,595		76,145
Accounts payable, accrued expenses and deferred revenue	(330,942)		(162,460)
Prepaid expenses	(20,656)		4,215
Employer pension contributions	(30,000)		(3,743)
Other, net	67,741		4,089
Net cash used by operating activities	(116,952)		(508)
INVESTING ACTIVITIES(1)
Business acquisitions, net of cash acquired	(1,815,329)		0
Purchase of property, plant and equipment	(45,730)		(39,074)
Contingent purchase price payments	(14,200)		(13,535)
Net cash used by investing activities	(1,875,259)	[1]	(52,609)	[1]
FINANCING ACTIVITIES(1)
Net proceeds from revolving credit facilities	1,673		95,000
Net payments on short-term borrowings	(24,723)		(647)
Repayment of credit facilities	(900,000)		(30,292)
Repayment of Warnaco’s previously outstanding debt	(197,000)		0
Net proceeds from credit facilities	2,993,430		0
Payment of fees associated with issuance of senior notes	(16,257)		0
Net proceeds from settlement of awards under stock plans	10,062		3,738
Excess tax benefits from awards under stock plans	14,788		2,912
Cash dividends	(6,130)		(5,483)
Acquisition of treasury shares	(20,130)		(6,182)
Payments of capital lease obligations	(2,348)		(2,447)
Net cash provided by financing activities	1,853,365	[1]	56,599	[1]
Effect of exchange rate changes on cash and cash equivalents	(7,082)		1,933
(Decrease) increase in cash and cash equivalents	(145,928)		5,415
Cash and cash equivalents at beginning of period	892,209		233,197
Cash and cash equivalents at end of period	$ 746,281		$ 238,612

[1] See Note 17 for information on noncash investing and financing transactions.